Boston, MA 06\/17\/2014 (wallstreetpr) \u2013 These days so many start-ups enter into market and take the level of servicing on new heights. Two modern era start-ups and now market leaders Medtronic, Inc. (NYSE:MDT) <\/b>and Covidien plc (NYSE:COV) <\/b>are the best examples of how market trends can be changed in a limited time period. But have you ever thought about possible events that can take place when these two modern age companies become one.<\/p>\n
Recently MDT announced that it would acquire COV to improve its service qualities. The deal is expected to cost MDT a huge sum of $43 billion.<\/p>\n
U.S Income Tax Issues: <\/b><\/p>\n
U.S lawmakers are not comfortable at all with MDT’s plan to buy COV and move its base permanently to Ireland. It will be a loss to Obama administration in terms of income tax receipts. According to an Oregon Democrat and the Chairman of the Senate Finance Committee Ron Wyden, “MDT and COV merger deal asks for an urgent need to introduce income tax reforms and make it harder for companies to reap tax instead of waiting till 2016 presidential election.”<\/p>\n
Medtronic, Inc. (NYSE:MDT)\u00a0and COV deal is a good example of inversion deal which has forced the federal lawmakers to think about tightening the income tax benefit rules. Though Wyden promised in the month of May to make income tax rules for inversion deals harder, but so far no such step has been taken by the government.
\n<\/b><\/p>\n
Levi & Korsinsky’s decision of investigating COV: <\/b><\/p>\n
As soon as the announcement of MDT and COV deal was made, Levi & Korsinsky decided to investigate COV’s Board of Directors for the possible breaches of state law and fiduciary duties in connection with the merger deal.
\n<\/b><\/p>\n
What is there for shareholders: <\/b><\/p>\n
Shareholders of COV will get $35.19 in cash and 0.956 shares of\u00a0Medtronic, Inc. (NYSE:MDT) for each stock of COV they have. So in total, shareholders of COV will get around $93.22 for each COV share.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 06\/17\/2014 (wallstreetpr) \u2013 These days so many start-ups enter into market and take the level of servicing on new heights. Two modern era […]<\/p>\n","protected":false},"author":15,"featured_media":26077,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,263],"tags":[7326,3021,7327,1022],"stock_ticker":[],"class_list":["post-26073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-technology","tag-covidien-plc-nysecov","tag-medtronic-inc-nysemdt","tag-nysecov","tag-nysemdt","entry"],"acf":[],"yoast_head":"\n